- Home
- PXED vs OLMA Comparison
PXED vs OLMA Comparison
Compare PXED & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PXED | OLMA |
|---|---|---|
| Founded | 1976 | 2006 |
| Country | United States | United States |
| Employees | 3400 | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 863.0M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | PXED | OLMA |
|---|---|---|
| Price | $33.11 | $11.39 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 10 |
| Target Price | $44.29 | ★ $44.89 |
| AVG Volume (30 Days) | 82.1K | ★ 1.7M |
| Earning Date | 04-07-2026 | 05-08-2026 |
| Dividend Yield | ★ 3.07% | N/A |
| EPS Growth | N/A | ★ 15.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $3.85 | N/A |
| Revenue Next Year | $4.49 | N/A |
| P/E Ratio | $11.20 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $23.52 | $4.12 |
| 52 Week High | $38.19 | $36.26 |
Technical Indicators
Market Signals| Indicator | PXED | OLMA |
|---|---|---|
| Relative Strength Index (RSI) | 59.69 | 49.34 |
| Support Level | $28.40 | $7.79 |
| Resistance Level | $33.05 | $11.54 |
| Average True Range (ATR) | 1.34 | 0.72 |
| MACD | 0.07 | 0.33 |
| Stochastic Oscillator | 91.44 | 79.93 |
Price Performance
Historical ComparisonAbout PXED Phoenix Education Partners Inc.
Phoenix Education Partners Inc. is a mission-driven organization operating at the forefront of the rapidly evolving post-secondary education market. it is an online education provider and a pioneer in its field. The company benefits from the dynamic interplay between technological innovation, education, employment, and economic trends. It is focused on delivering personalized, career-relevant, and affordable education to its students through its flexible learning model, skills-aligned curriculum, and accessible tuition costs.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.